GE HealthCare Technologies (GEHC) is currently undergoing significant advancements in cardiac procedures through AI solutions, enhancing diagnostic imaging with the help of autonomous X-ray and ultrasound solutions, in collaboration with
NVIDIA (NVDA). This critical partnership also aims to advance the development of AI and physical AI in autonomous diagnostic imaging. In an attempt to accelerate early cancer detection, GEHC has expanded its cardiology solutions portfolio. With the help of its newly unveiled AltiX AI.i, GEHC expects to elevate the experience in catheterization lab procedures. Meanwhile, the stock has been upgraded by
Goldman Sachs, indicating a positive market sentiment towards the company. Further strengthening their market position, GE Healthcare announces their Genesis Cloud Solutions to advance digital healthcare transformation and has also launched Freelium, a next-generation sealed magnet platform. This is amidst the company’s forecast of an upbeat profit for 2025 due to steady medical device demand. Nevertheless, some bearish signals have been detected with insiders disposing off their stocks.
Ge Healthcare Technologies GEHC News Analytics from Thu, 12 Sep 2024 07:00:00 GMT to Sat, 22 Mar 2025 18:29:55 GMT -
Rating 3
- Innovation 6
- Information 7
- Rumor 5
